Thibaut Mongon's remarks follow Kenvue's second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and Aveeno.
from Health and Science https://ift.tt/qo0SXZ1
https://ift.tt/7MFshI6
https://ift.tt/2yCK94w
No comments:
Post a Comment